Erratum: Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. (Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial (2011) 188(3) (361–365), (S0165178111003611), (10.1016/j.psychres.2011.04.030));Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial

Psychiatry Research

Volumn 188, Issue 3, 2011, Pages 361-365

  Prisciandaro, James J ^a   Brown, Delisa G ^a   Brady, Kathleen T ^a   Tolliver, Bryan K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; Anxiety; Bipolar; Depression; Mania; Relapse

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR MANIA; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPATHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

EID: 79960696938     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2020.112904     Document Type: Erratum

References (31)

1. Anton R.F., Moak D.H., Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism, Clinical and Experimental Research 2006, 19:92-99.
2. Brown E.S., Garza M., Carmody T.J. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. The Journal of Clinical Psychiatry 2008, 69:701-705.
3. Feinman J.A., Dunner D.L. The effect of alcohol and substance abuse on the course of bipolar affective disorder. Journal of Affective Disorders 1996, 37:43-49.
4. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders 1996, Research Version, New York State Psychiatric Institute, New York. Patient Edition.
5. Gao K., Chan P.K., Verduin M.L., Kemp D.E., Tolliver B.K., Ganocy S.J., Bilali S., Brady K.T., Findling R.L., Calabrese J.R. Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders. The American Journal on Addictions 2010, 19:440-449.
6. Geller B., Cooper T.B., Sun K., Zimmerman B., Frazier J., Williams M., Heath J. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37:171-178.
7. Goldberg J.F., Garno J.L., Leon A.C., Kocsis J.H., Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. The Journal of Clinical Psychiatry 1999, 60:733-740.
8. Goldstein B.I., Levitt A.J. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disorders 2008, 10:67-78.
9. Herzog W., Boomsma A. Small-sample robust estimators of noncentrality-based and incremental model fit. Structural Equation Modeling 2009, 16:1-27.
10. Himmelhoch J.M., Garfinkel M.E. Sources of lithium resistance in mixed mania. Psychopharmacology Bulletin 1986, 22:613-620.
11. Kemp D.E., Gao K., Ganocy S.J., Ehhaj O., Bilali S.R., Conroy C., Findling R.L., Calabrese J.R. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. The Journal of Clinical Psychiatry 2009, 70:113-121.
12. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:617-627.
13. Kolodziej M.E., Griffin M.L., Najavits L.M., Otto M.W., Greenfield S.F., Weiss R.D. Anxiety disorders among patients with co-occurring bipolar and substance use disorders. Drug and Alcohol Dependence 2005, 80:251-257.
14. Levander E., Frye M.A., McElroy S., Suppes T., Grunze H., Nolen W.A., Kupka R., Keck P.E., Leverich G.S., Altshuler L.L., Hwang S., Mintz J., Post R.M. Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. Journal of Affective Disorders 2007, 101:211-217.
15. McElroy S.L., Altshuler L.L., Suppes T., Frye M.A., Denicoff K.D., Nolen W.A., Kupka R.W., Leverich G.S., Rochussen J.R., Rush A.J., Post R.M. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. The American Journal of Psychiatry 2001, 158:420-426.
16. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M., Petukhova M., Kessler R.C. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry 2007, 64:543-552.
17. Montgomery S.A., Asberg M.A. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry 1979, 134:382-389.
18. Muthén L.K., Muthén B.O. Mplus User's Guide 2009, Muthén & Muthén, Los Angeles, CA. Fifth Edition.
19. Passmore M.J., Garnham J., Duffy A., MacDougall M., Munro A., Slaney C., Teehan A., Alda M. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disorders 2003, 5:110-114.
20. Reiger D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association 1990, 264:2511-2518.
21. Salloum I.M., Cornelius J.R., Daley D.C., Kirisci L., Himmelhoch J.M., Thase M.E. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Archives of General Psychiatry 2005, 62:37-45.
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavas J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 1998, 59:22-33.
23. Simon N.M., Otto M.W., Wisniewski S.R., Fossey M., Sagduyu K., Frank E., Sachs G.S., Nierenberg A.A., Thase M.E., Pollack M.H. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry 2004, 161:2222-2229.
24. Simon N.M., Otto M.W., Weiss R.D., Bauer M.S., Miyahara S., Wisniewski S.R., Thase M.E., Kogan J., Frank E., Nierenberg A.A., Calabrese J.R., Sachs G.S., Pollack M.H. Pharmacotherapy for bipolar disorder and comorbid conditions. Baseline data from STEP-BD. Journal of Clinical Psychopharmacology 2004, 24:512-520.
25. Sobell L.C., Sobell M.B. Timeline Followback User's Guide: a Calendar Method for Assessing Alcohol and Drug Use 1996, Addiction Research Foundation, Toronto.
26. Stedman M., Pettinati H.M., Brown E.S., Kotz M., Calabrese J.R., Raines S. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcoholism, Clinical and Experimental Research 2010, 34:1822-1831.
27. Swain A.J. Analysis of parametric structures for variance matrices 1975, Unpublished doctoral dissertation, Department of Statistics, University of Adelaide, Australia.
28. Tolliver, B.K., Brown, D.G., Simpson, A.N., DeSantis, S.M., Prisciandaro, J.J., Brady, K.T., submitted for publication. A Randomized, Double-blind, Placebo-controlled Clinical Trial of Acamprosate in Alcohol-dependent Individuals with Bipolar Disorder.
29. Tohen M., Greenfield S.F., Weiss R.D., Zarate C.A., Vagge L.M. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harvard Review of Psychiatry 1998, 6:133-141.
30. Weiss R.D., Ostacher M.J., Otto M.W., Calabrese J.R., Fossey M., Wisniewski S.R., Bowden C.L., Nierenberg A.A., Pollack M.H., Salloum I.M., Simon N.M., Thase M.E., Sachs G.S. Does recovery from substance use disorder matter in patients with bipolar disorder?. The Journal of Clinical Psychiatry 2005, 66:730-735.
31. Young R., Biggs J., Meyer D. A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry 1978, 133:429-435.